These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 20302432)

  • 21. Re-emergence of Chlamydia trachomatis infection after mass antibiotic treatment of a trachoma-endemic Gambian community: a longitudinal study.
    Burton MJ; Holland MJ; Makalo P; Aryee EA; Alexander ND; Sillah A; Faal H; West SK; Foster A; Johnson GJ; Mabey DC; Bailey RL
    Lancet; 2005 Apr 9-15; 365(9467):1321-8. PubMed ID: 15823382
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Targeted Mass Azithromycin Distribution for Trachoma: A Community-Randomized Trial (TANA II).
    Mahmud H; Haile BA; Tadesse Z; Gebresillasie S; Shiferaw A; Zerihun M; Liu Z; Callahan EK; Cotter SY; Varnado NE; Oldenburg CE; Porco TC; Lietman TM; Keenan JD
    Clin Infect Dis; 2023 Aug; 77(3):388-395. PubMed ID: 37021692
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Complete elimination is a difficult goal for trachoma programs in severely affected communities.
    Gill DA; Lakew T; Alemayehu W; Melese M; Zhou Z; House JI; Hong KC; Ray KJ; Gandhi N; Whitcher JP; Gaynor BD; Lietman TM
    Clin Infect Dis; 2008 Feb; 46(4):564-6. PubMed ID: 18194094
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mass treatment with single-dose azithromycin for trachoma.
    Solomon AW; Holland MJ; Alexander ND; Massae PA; Aguirre A; Natividad-Sancho A; Molina S; Safari S; Shao JF; Courtright P; Peeling RW; West SK; Bailey RL; Foster A; Mabey DC
    N Engl J Med; 2004 Nov; 351(19):1962-71. PubMed ID: 15525721
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Risk factors for active trachoma and Chlamydia trachomatis infection in rural Ethiopia after mass treatment with azithromycin.
    Edwards T; Harding-Esch EM; Hailu G; Andreason A; Mabey DC; Todd J; Cumberland P
    Trop Med Int Health; 2008 Apr; 13(4):556-65. PubMed ID: 18282237
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Trachoma and ocular Chlamydia trachomatis were not eliminated three years after two rounds of mass treatment in a trachoma hyperendemic village.
    West SK; Munoz B; Mkocha H; Gaydos C; Quinn T
    Invest Ophthalmol Vis Sci; 2007 Apr; 48(4):1492-7. PubMed ID: 17389476
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Trachoma prevalence remains below threshold in five districts after stopping mass drug administration: results of five surveillance surveys within a hyperendemic setting in Amhara, Ethiopia.
    Nash SD; Stewart AEP; Astale T; Sata E; Zerihun M; Gessese D; Melak B; Ayenew G; Ayele Z; Bayissasse B; Chanyalew M; Tadesse Z; Callahan EK
    Trans R Soc Trop Med Hyg; 2018 Dec; 112(12):538-545. PubMed ID: 30265355
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Eliminating trachoma in areas with limited disease.
    Gaynor BD; Miao Y; Cevallos V; Jha H; Chaudary JS; Bhatta R; Osaki-Holm S; Yi E; Schachter J; Whitcher JP; Lietman T
    Emerg Infect Dis; 2003 May; 9(5):596-8. PubMed ID: 12737745
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Risk of Infection with Chlamydia trachomatis from Migrants to Communities Undergoing Mass Drug Administration for Trachoma Control.
    West SK; Munoz BE; Mkocha H; Gaydos C; Quinn T
    Ophthalmic Epidemiol; 2015; 22(3):170-5. PubMed ID: 26158574
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The epidemiological dynamics of infectious trachoma may facilitate elimination.
    Lietman TM; Gebre T; Ayele B; Ray KJ; Maher MC; See CW; Emerson PM; Porco TC;
    Epidemics; 2011 Jun; 3(2):119-24. PubMed ID: 21624783
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Ocular Chlamydia trachomatis infection and infectious load among pre-school aged children within trachoma hyperendemic districts receiving the SAFE strategy, Amhara region, Ethiopia.
    Nash SD; Chernet A; Moncada J; Stewart AEP; Astale T; Sata E; Zerihun M; Gessese D; Melak B; Ayenew G; Ayele Z; Chanyalew M; Lietman TM; Callahan EK; Schachter J; Tadesse Z
    PLoS Negl Trop Dis; 2020 May; 14(5):e0008226. PubMed ID: 32421719
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Population-Based Prevalence of Ocular Chlamydia trachomatis Infection among Infants in the Trachoma Endemic Amhara Region, Ethiopia.
    Nash SD; Chernet A; Astale T; Sata E; Zerihun M; Nute AW; Jensen KA; Gessese D; Ayele Z; Melak B; Haile M; Zeru T; Tadesse Z; Kelly Callahan E
    Am J Trop Med Hyg; 2021 Oct; 106(1):62-65. PubMed ID: 34695789
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prevalence of Ocular Chlamydia trachomatis Infection in Amhara Region, Ethiopia, after 8 Years of Trachoma Control Interventions.
    Nash SD; Chernet A; Weiss P; Nute AW; Zerihun M; Sata E; Gessese D; Jensen KA; Ayele Z; Melak B; Zeru T; Mengistu A; Abebe A; Seife F; Tadesse Z; Callahan EK
    Am J Trop Med Hyg; 2023 Feb; 108(2):261-267. PubMed ID: 36623484
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical activity and polymerase chain reaction evidence of chlamydial infection after repeated mass antibiotic treatments for trachoma.
    Keenan JD; Lakew T; Alemayehu W; Melese M; Porco TC; Yi E; House JI; Zhou Z; Ray KJ; Acharya NR; Whitcher JP; Gaynor BD; Lietman TM
    Am J Trop Med Hyg; 2010 Mar; 82(3):482-7. PubMed ID: 20207878
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mass treatment and the effect on the load of Chlamydia trachomatis infection in a trachoma-hyperendemic community.
    West ES; Munoz B; Mkocha H; Holland MJ; Aguirre A; Solomon AW; Bailey R; Foster A; Mabey D; West SK
    Invest Ophthalmol Vis Sci; 2005 Jan; 46(1):83-7. PubMed ID: 15623758
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Which members of a community need antibiotics to control trachoma? Conjunctival Chlamydia trachomatis infection load in Gambian villages.
    Burton MJ; Holland MJ; Faal N; Aryee EA; Alexander ND; Bah M; Faal H; West SK; Foster A; Johnson GJ; Mabey DC; Bailey RL
    Invest Ophthalmol Vis Sci; 2003 Oct; 44(10):4215-22. PubMed ID: 14507864
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The Prevalence of Trachoma in Tigray Region, Northern Ethiopia: Results of 11 Population-Based Prevalence Surveys Completed as Part of the Global Trachoma Mapping Project.
    Sherief ST; Macleod C; Gigar G; Godefay H; Abraha A; Dejene M; Kello AB; Belete A; Assefa Y; Willis R; Chu BK; Solomon AW
    Ophthalmic Epidemiol; 2016; 23(sup1):94-99. PubMed ID: 27918232
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Antibiotics for trachoma.
    Evans JR; Solomon AW
    Cochrane Database Syst Rev; 2011 Mar; (3):CD001860. PubMed ID: 21412875
    [TBL] [Abstract][Full Text] [Related]  

  • 39. When the Neighboring Village is Not Treated: Role of Geographic Proximity to Communities Not Receiving Mass Antibiotics for Trachoma.
    Mosenia A; Haile BA; Shiferaw A; Gebresillasie S; Gebre T; Zerihun M; Tadesse Z; Emerson PM; Callahan EK; Zhou Z; Lietman TM; Keenan JD
    Clin Infect Dis; 2023 Mar; 76(6):1038-1042. PubMed ID: 36477547
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Feasibility of eliminating ocular Chlamydia trachomatis with repeat mass antibiotic treatments.
    Melese M; Chidambaram JD; Alemayehu W; Lee DC; Yi EH; Cevallos V; Zhou Z; Donnellan C; Saidel M; Whitcher JP; Gaynor BD; Lietman TM
    JAMA; 2004 Aug; 292(6):721-5. PubMed ID: 15304470
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.